CLINUVEL Investor Webinar for half year results ending 31 December 2023

CLINUVEL PHARMACEUTICALS LTD held an investor webinar to review the half year results to 31 December 2023, hosted by Mr Malcolm Bull, Head of Investor Relations, and joined by Mr Darren Keamy, Chief Financial Officer, and Mr Lachlan Hay, Director of Global Operations.

The full results are available in the Appendix 4D.
The accompanying announcement is available on our website.

Related Articles

Get in Touch


Latest Posts